Measles virus and rinderpest virus divergence dated to the sixth century BCE.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
19 06 2020
Historique:
received: 17 01 2020
accepted: 30 04 2020
entrez: 20 6 2020
pubmed: 20 6 2020
medline: 9 7 2020
Statut: ppublish

Résumé

Many infectious diseases are thought to have emerged in humans after the Neolithic revolution. Although it is broadly accepted that this also applies to measles, the exact date of emergence for this disease is controversial. We sequenced the genome of a 1912 measles virus and used selection-aware molecular clock modeling to determine the divergence date of measles virus and rinderpest virus. This divergence date represents the earliest possible date for the establishment of measles in human populations. Our analyses show that the measles virus potentially arose as early as the sixth century BCE, possibly coinciding with the rise of large cities.

Identifiants

pubmed: 32554594
pii: 368/6497/1367
doi: 10.1126/science.aba9411
pmc: PMC7713999
mid: NIHMS1648186
doi:

Types de publication

Historical Article Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1367-1370

Subventions

Organisme : NIAID NIH HHS
ID : U19 AI135995
Pays : United States
Organisme : European Research Council
Pays : International

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Références

Syst Biol. 2018 Sep 1;67(5):901-904
pubmed: 29718447
Emerg Infect Dis. 2014 Dec;20(12):2023-33
pubmed: 25418782
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Prev Vet Med. 2005 Jul 12;69(3-4):245-63
pubmed: 15907573
Virol J. 2010 Mar 04;7:52
pubmed: 20202190
PLoS Biol. 2019 Jul 30;17(7):e3000166
pubmed: 31361744
N Engl J Med. 2012 Nov 22;367(21):2057-9
pubmed: 23171117
J R Soc Interface. 2012 Jan 7;9(66):89-101
pubmed: 21632614
Mol Biol Evol. 2020 Nov 1;37(11):3363-3379
pubmed: 32895707
Syst Biol. 2019 Nov 1;68(6):1052-1061
pubmed: 31034053
Mol Biol Evol. 1994 Sep;11(5):725-36
pubmed: 7968486
Philos Trans R Soc Lond B Biol Sci. 2013 Jun 24;368(1623):20120139
pubmed: 23798687
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Mol Biol Evol. 2000 Jul;17(7):1081-90
pubmed: 10889221
Sci Rep. 2015 Jul 01;5:11648
pubmed: 26130388
Virus Evol. 2018 Jun 08;4(1):vey016
pubmed: 29942656
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Mol Phylogenet Evol. 2003 Jan;26(1):1-7
pubmed: 12470932
Mol Ecol. 2015 Dec;24(24):6007-12
pubmed: 26769402
Adv Virus Res. 1999;53:89-110
pubmed: 10582096
J Virol. 1997 Feb;71(2):1265-71
pubmed: 8995650
J Med Virol. 1999 Jul;58(3):313-20
pubmed: 10447429
Virus Evol. 2015 May 26;1(1):vev003
pubmed: 27774277
Nature. 2018 May;557(7705):418-423
pubmed: 29743673
MMWR Morb Mortal Wkly Rep. 2018 Nov 30;67(47):1323-1329
pubmed: 30496160
Curr Biol. 2016 Dec 19;26(24):3407-3412
pubmed: 27939314
Mol Biol Evol. 2011 Dec;28(12):3355-65
pubmed: 21705379
J Gen Virol. 2002 Jun;83(Pt 6):1419-1430
pubmed: 12029157
Mol Biol Evol. 2019 Aug 1;36(8):1793-1803
pubmed: 31004175
Virus Genes. 2011 Oct;43(2):249-53
pubmed: 21643766
Bioinformatics. 2013 Jul 01;29(13):1682-4
pubmed: 23613487
Genome Res. 2017 May;27(5):824-834
pubmed: 28298430
Science. 2010 Aug 6;329(5992):676-9
pubmed: 20689015
PLoS Comput Biol. 2014 Apr 03;10(4):e1003505
pubmed: 24699231
Methods Ecol Evol. 2015 Jan;6(1):83-91
pubmed: 25893087
PLoS Pathog. 2018 Jan 4;14(1):e1006750
pubmed: 29300782
Infect Genet Evol. 2014 Jun;24:76-81
pubmed: 24642136
Infect Dis Clin North Am. 2004 Mar;18(1):79-100
pubmed: 15081506
Elife. 2018 May 10;7:
pubmed: 29745896
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Evol Appl. 2018 Jul 23;12(1):123-136
pubmed: 30622640
Am J Dis Child. 1962 Mar;103:224-6
pubmed: 14462174
Nat Commun. 2012 Apr 24;3:796
pubmed: 22531181
Virus Evol. 2016 Apr 09;2(1):vew007
pubmed: 27774300
J Theor Biol. 1966 Jul;11(2):207-11
pubmed: 5965486
Science. 2019 Nov 1;366(6465):599-606
pubmed: 31672891
J Virol. 2016 Jul 27;90(16):7184-95
pubmed: 27252529
Science. 1997 Jan 3;275(5296):65-7
pubmed: 8974392
Emerg Infect Dis. 2013 Dec;19(12):2037-40
pubmed: 24274684
PLoS One. 2007 Jun 20;2(6):e537
pubmed: 17579711
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Nature. 2007 May 17;447(7142):279-83
pubmed: 17507975
Proc Natl Acad Sci U S A. 2018 Jul 17;115(29):7557-7562
pubmed: 29967156
Sci Rep. 2017 May 16;7(1):1974
pubmed: 28512347
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712
J Gen Virol. 2000 Aug;81(Pt 8):1927-1932
pubmed: 10900029
Lancet. 2017 Dec 2;390(10111):2490-2502
pubmed: 28673424
Res Vet Sci. 2019 Jun;124:118-122
pubmed: 30878633

Auteurs

Ariane Düx (A)

Epidemiology of Highly Pathogenic Microorganisms Project Group, Robert Koch Institute, Berlin, Germany.
Viral Evolution Project Group, Robert Koch Institute, Berlin, Germany.

Sebastian Lequime (S)

Laboratory of Clinical and Evolutionary Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute, Katholieke Universiteit (KU) Leuven, Leuven, Belgium.

Livia Victoria Patrono (LV)

Epidemiology of Highly Pathogenic Microorganisms Project Group, Robert Koch Institute, Berlin, Germany.
Viral Evolution Project Group, Robert Koch Institute, Berlin, Germany.

Bram Vrancken (B)

Laboratory of Clinical and Evolutionary Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute, Katholieke Universiteit (KU) Leuven, Leuven, Belgium.

Sengül Boral (S)

Institute for Pathology, Charité, Berlin, Germany.

Jan F Gogarten (JF)

Epidemiology of Highly Pathogenic Microorganisms Project Group, Robert Koch Institute, Berlin, Germany.
Viral Evolution Project Group, Robert Koch Institute, Berlin, Germany.

Antonia Hilbig (A)

Epidemiology of Highly Pathogenic Microorganisms Project Group, Robert Koch Institute, Berlin, Germany.

David Horst (D)

Institute for Pathology, Charité, Berlin, Germany.

Kevin Merkel (K)

Epidemiology of Highly Pathogenic Microorganisms Project Group, Robert Koch Institute, Berlin, Germany.
Viral Evolution Project Group, Robert Koch Institute, Berlin, Germany.

Baptiste Prepoint (B)

Viral Evolution Project Group, Robert Koch Institute, Berlin, Germany.
Département de Biologie, Ecole Normale Supérieure, PSL Université Paris, Paris, France.

Sabine Santibanez (S)

National Reference Centre for Measles, Mumps, and Rubella, Robert Koch Institute, Berlin, Germany.

Jasmin Schlotterbeck (J)

Viral Evolution Project Group, Robert Koch Institute, Berlin, Germany.

Marc A Suchard (MA)

Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA, USA.
Department of Biomathematics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.

Markus Ulrich (M)

Epidemiology of Highly Pathogenic Microorganisms Project Group, Robert Koch Institute, Berlin, Germany.

Navena Widulin (N)

Berlin Museum of Medical History, Charité, Berlin, Germany.

Annette Mankertz (A)

National Reference Centre for Measles, Mumps, and Rubella, Robert Koch Institute, Berlin, Germany.

Fabian H Leendertz (FH)

Epidemiology of Highly Pathogenic Microorganisms Project Group, Robert Koch Institute, Berlin, Germany.

Kyle Harper (K)

Department of Classics and Letters, University of Oklahoma, Norman, OK, USA.

Thomas Schnalke (T)

Berlin Museum of Medical History, Charité, Berlin, Germany.

Philippe Lemey (P)

Laboratory of Clinical and Evolutionary Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute, Katholieke Universiteit (KU) Leuven, Leuven, Belgium.

Sébastien Calvignac-Spencer (S)

Epidemiology of Highly Pathogenic Microorganisms Project Group, Robert Koch Institute, Berlin, Germany. calvignacs@rki.de.
Viral Evolution Project Group, Robert Koch Institute, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH